3 hours Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives Average Recommendation of “Moderate Buy” from Analysts MarketBeat
Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) has received an average rating of “Moderate Buy” from the seven research firms that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a…